Matthew J. Garnett
- Molecular Biology
- Neurology top 10%
- Hematology top 10%
- Cancer Research
- Oncology
- Co-authors
- Kimberly StegmaierStacey M. FrummPatricia GreningerCyril H. BenesGabriela AlexeAlexandre PuissantWilliam A. WeissJun Qi
- Topics
- Protein Degradation and Inhibitors (2 papers)Multiple Myeloma Research and Treatments (1 paper)Neuroblastoma Research and Treatments (1 paper)
- Cited by
- NeurologyHematologyMolecular Biology
- Journals
- Cancer ResearchCancer Discovery
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Matthew J. Garnett
2 papers receiving 457 citations
Hit Papers
Peers
Comparison fields: 5 of 30
- Molecular Biology 396
- Neurology 190
- Hematology 103
- Cancer Research 81
- Oncology 75
Countries citing papers authored by Matthew J. Garnett
This map shows the geographic impact of Matthew J. Garnett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew J. Garnett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew J. Garnett more than expected).
Fields of papers citing papers by Matthew J. Garnett
This network shows the impact of papers produced by Matthew J. Garnett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew J. Garnett. The network helps show where Matthew J. Garnett may publish in the future.
Co-authorship network of co-authors of Matthew J. Garnett
This figure shows the co-authorship network connecting the top 25 collaborators of Matthew J. Garnett. A scholar is included among the top collaborators of Matthew J. Garnett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew J. Garnett. Matthew J. Garnett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Targeting MYCN in Neuroblastoma by BET Bromodomain Inhibitionbreakdown → | 457 |
| 2 | 3 |
About Matthew J. Garnett
Matthew J. Garnett is a scholar working on Hematology, Neurology and Molecular Biology, having authored 2 papers that have together received 460 indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (2 papers), Multiple Myeloma Research and Treatments (1 paper) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Neurology (190 citations), Hematology (103 citations) and Molecular Biology (396 citations). Matthew J. Garnett has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Kimberly Stegmaier, Stacey M. Frumm, Patricia Greninger, Cyril H. Benes, Gabriela Alexe, Alexandre Puissant, William A. Weiss, Jun Qi, Rhamy Zeid and W. Clay Gustafson. Their work appears in journals such as Cancer Research and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.